BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2082 related articles for article (PubMed ID: 30231877)

  • 21. Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications.
    Ai X; Hu M; Wang Z; Zhang W; Li J; Yang H; Lin J; Xing B
    Bioconjug Chem; 2018 Apr; 29(4):838-851. PubMed ID: 29509403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.
    Kompella UB; Amrite AC; Pacha Ravi R; Durazo SA
    Prog Retin Eye Res; 2013 Sep; 36():172-98. PubMed ID: 23603534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis.
    Mignani S; Shi X; Rodrigues J; Roy R; Muñoz-Fernández Á; Ceña V; Majoral JP
    Bioconjug Chem; 2020 Sep; 31(9):2060-2071. PubMed ID: 32786368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.
    Havel HA
    AAPS J; 2016 Nov; 18(6):1351-1353. PubMed ID: 27520380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advancement of nanoscience in development of conjugated drugs for enhanced disease prevention.
    Taneja P; Sharma S; Sinha VB; Yadav AK
    Life Sci; 2021 Mar; 268():118859. PubMed ID: 33358907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
    Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
    Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in drug delivery: potential and limitations of carbon nanotubes.
    Prakash S; Kulamarva AG
    Recent Pat Drug Deliv Formul; 2007; 1(3):214-21. PubMed ID: 19075888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives.
    Rehan F; Zhang M; Fang J; Greish K
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinspired Platform Conjugated Active Drug Delivery.
    Shao J; Xuan M; He Q; Dai L
    Curr Drug Targets; 2018 Feb; 19(4):328-338. PubMed ID: 27262485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-Based Drug Delivery and Use of Nano-and Microcarriers for Cell Functionalization.
    Timin AS; Litvak MM; Gorin DA; Atochina-Vasserman EN; Atochin DN; Sukhorukov GB
    Adv Healthc Mater; 2018 Feb; 7(3):. PubMed ID: 29193876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.
    Maurya S; Srivastava R; Arfin S; Hawthorne S; Jha NK; Agrawal K; Raj S; Rathi B; Kumar A; Raj R; Agrawal S; Paiva-Santos AC; Malik AA; Dua K; Rana R; Ojha S; Jha SK; Sharma A; Kumar D; El-Zahaby SA; Nagar A
    Nanomedicine (Lond); 2022 Dec; 17(30):2245-2264. PubMed ID: 36975758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Overview of Green Synthesis and Potential Pharmaceutical Applications of Nanoparticles as Targeted Drug Delivery System in Biomedicines.
    Mittal S; Chakole CM; Sharma A; Pandey J; Chauhan MK
    Drug Res (Stuttg); 2022 Jun; 72(5):274-283. PubMed ID: 35562101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of nanotechnology in developing new therapies for diseases of the nervous system.
    Jain KK
    Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
    [No Abstract]   [Full Text] [Related]  

  • 37. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smart drug delivery nanocarriers with self-assembled DNA nanostructures.
    Li J; Fan C; Pei H; Shi J; Huang Q
    Adv Mater; 2013 Aug; 25(32):4386-96. PubMed ID: 23765613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoscale Delivery Systems: Actual and Potential Applications in the Natural Products Industry.
    Simona AD; Florina A; Rodica CA; Evelyne O; Maria-Corina S
    Curr Pharm Des; 2017; 23(17):2414-2421. PubMed ID: 28228070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review.
    Ramasamy T; Ruttala HB; Gupta B; Poudel BK; Choi HG; Yong CS; Kim JO
    J Control Release; 2017 Jul; 258():226-253. PubMed ID: 28472638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 105.